Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie J Howell

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Neuroinflammation|September 8, 2018
Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathologySarah M Rothman, Keith Q Tanis, Pallavi Gandhi, et al.
International Journal of Molecular Sciences|January 25, 2025
An Immunocytochemistry Method to Investigate the Translationally Active HIV ReservoirGuoxin Wu, Samuel H Keller, Ryan T Walters, et al.
Bioconjugate Chemistry|March 19, 2013
Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeuticsRubina Giare Parmar, Marina Busuek, Eileen S Walsh, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding GroupJian Liu, Younong Yu, Joseph Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNAFrancesco R Simonetti, Jennifer A White, Camille Tumiotto, et al.
JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.
The Journal of Infectious Diseases|March 11, 2021
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune ResponseGuoxin Wu, Paul Zuck, Shih Lin Goh, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2020
Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivationWensheng Yu, Jian Liu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for ClearanceJian Liu, Joseph Kelly, Wensheng Yu, et al.
Journal of Medicinal Chemistry|April 2, 2021
Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG ActivityWensheng Yu, Jian Liu, Dane Clausen, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Neuroinflammation|September 8, 2018
Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathologySarah M Rothman, Keith Q Tanis, Pallavi Gandhi, et al.
International Journal of Molecular Sciences|January 25, 2025
An Immunocytochemistry Method to Investigate the Translationally Active HIV ReservoirGuoxin Wu, Samuel H Keller, Ryan T Walters, et al.
Bioconjugate Chemistry|March 19, 2013
Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeuticsRubina Giare Parmar, Marina Busuek, Eileen S Walsh, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding GroupJian Liu, Younong Yu, Joseph Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2020
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNAFrancesco R Simonetti, Jennifer A White, Camille Tumiotto, et al.
JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.
The Journal of Infectious Diseases|March 11, 2021
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune ResponseGuoxin Wu, Paul Zuck, Shih Lin Goh, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2020
Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivationWensheng Yu, Jian Liu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for ClearanceJian Liu, Joseph Kelly, Wensheng Yu, et al.
Journal of Medicinal Chemistry|April 2, 2021
Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG ActivityWensheng Yu, Jian Liu, Dane Clausen, et al.
Pageof 6